Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

More On ANP.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Antisense Therapeutics Ltd. (ANP.AX)

-ASX
0.13 0.00(0.00%) 1:14AM EDT
Prev Close:0.13
Open:0.13
Bid:0.13
Ask:0.14
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.12 - 0.13
52wk Range:0.10 - 0.23
Volume:1,301,031
Avg Vol (3m):169,224
Market Cap:18.73M
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antisense Therapeutics Limited develops and commercializes novel antisense therapeutics in the United States, Canada, Japan, Australia, and Europe. The company’s product pipeline comprises ATL1103, a Phase II clinical trial drug to block grow... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback